Terms: = Cervical cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
45 results:
1. Effects of brd4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
Zheng J; Huang B; Xiao L; Wu M
PeerJ; 2024; 12():e17035. PubMed ID: 38410799
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and feasibility of 3D printed redesigned Venezia™ applicator for treating advanced cervix and recurrent endometrial cancer.
Lee VWY; Yip WWL; Tang SYK; Leung MPH; Kwan KKK; Liu ACH; Chan VNY; Wu JWS; Cheng JNS; Chiang CL; Ho-Fun Lee V
Phys Med; 2023 Oct; 114():103150. PubMed ID: 37757501
[TBL] [Abstract] [Full Text] [Related]
3. Human Papillomavirus 16 E2 Interaction with TopBP1 Is Required for E2 and Viral Genome Stability during the Viral Life Cycle.
Prabhakar AT; James CD; Fontan CT; Otoa R; Wang X; Bristol ML; Hill RD; Dubey A; Morgan IM
J Virol; 2023 Mar; 97(3):e0006323. PubMed ID: 36840558
[TBL] [Abstract] [Full Text] [Related]
4.
Darabi S; Braxton DR; Xiu J; Carneiro BA; Swensen J; Antonarakis ES; Liu SV; McKay RR; Spetzler D; El-Deiry WS; Demeure MJ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557020
[No Abstract] [Full Text] [Related]
5. Updated Review on Pathology of Endocervical Adenocarcinoma with Emphasis on Clinically Relevant Findings.
Cimic A; Liu-Jarin X
Acta Med Acad; 2021 Apr; 50(1):126-135. PubMed ID: 34075768
[TBL] [Abstract] [Full Text] [Related]
6. brd4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
Ni M; Li J; Zhao H; Xu F; Cheng J; Yu M; Ke G; Wu X
Oncogene; 2021 Apr; 40(15):2711-2724. PubMed ID: 33712705
[TBL] [Abstract] [Full Text] [Related]
7. Synergistic Therapy for cervical cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.
Wang Y; Shen N; Li S; Yu H; Wang Y; Liu Z; Han L; Tang Z
Nano Lett; 2021 Mar; 21(6):2412-2421. PubMed ID: 33705152
[TBL] [Abstract] [Full Text] [Related]
8. Photodynamic and Cold Atmospheric Plasma Combination Therapy Using Polymeric Nanoparticles for the Synergistic treatment of cervical cancer.
Ha JH; Kim YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33504007
[TBL] [Abstract] [Full Text] [Related]
9. Imaging spectrum of NUT carcinomas.
Virarkar M; Saleh M; Ramani NS; Morani AC; Bhosale P
Clin Imaging; 2020 Nov; 67():198-206. PubMed ID: 32866821
[TBL] [Abstract] [Full Text] [Related]
10. cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract] [Full Text] [Related]
11. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Effects and Tissue Penetration Depth of Physical Plasma in Human Mucosa Analyzed by Contact- and Marker-Independent Raman Microspectroscopy.
Wenzel T; Carvajal Berrio DA; Daum R; Reisenauer C; Weltmann KD; Wallwiener D; Brucker SY; Schenke-Layland K; Brauchle EM; Weiss M
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42885-42895. PubMed ID: 31657892
[TBL] [Abstract] [Full Text] [Related]
13. Synthesis of titanium dioxide nanotubes with liposomal covers for carrying and extended release of 5-FU as anticancer drug in the treatment of HeLa cells.
Heidari Khoee M; Khoee S; Lotfi M
Anal Biochem; 2019 May; 572():16-24. PubMed ID: 30831100
[TBL] [Abstract] [Full Text] [Related]
14. brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Rataj O; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Int J Cancer; 2019 May; 144(9):2330-2338. PubMed ID: 30421459
[TBL] [Abstract] [Full Text] [Related]
15. See, Test & Treat: A 5-Year Experience of Pathologists Driving cervical and Breast cancer Screening to Underserved and Underinsured Populations.
Magnani B; Harubin B; Katz JF; Zuckerman AL; Strohsnitter WC
Arch Pathol Lab Med; 2016 Dec; 140(12):1411-1422. PubMed ID: 27922769
[TBL] [Abstract] [Full Text] [Related]
16. Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
Akasaki Y; Kikuchi T; Homma S; Koido S; Ohkusa T; Tasaki T; Hayashi K; Komita H; Watanabe N; Suzuki Y; Yamamoto Y; Mori R; Arai T; Tanaka T; Joki T; Yanagisawa T; Murayama Y
Cancer Immunol Immunother; 2016 Dec; 65(12):1499-1509. PubMed ID: 27688162
[TBL] [Abstract] [Full Text] [Related]
17. Tandemly Integrated HPV16 Can Form a brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes.
Dooley KE; Warburton A; McBride AA
mBio; 2016 Sep; 7(5):. PubMed ID: 27624132
[TBL] [Abstract] [Full Text] [Related]
18. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract] [Full Text] [Related]
19. ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism.
Liwak-Muir U; Dobson CC; Naing T; Wylie Q; Chehade L; Baird SD; Chakraborty PK; Holcik M
Oncotarget; 2016 Jan; 7(2):1439-50. PubMed ID: 26595526
[TBL] [Abstract] [Full Text] [Related]
20. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract] [Full Text] [Related]
[Next]
